The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Danuta Gąsior-PerczakIwona PałygaMonika SzymonekArtur KowalikAgnieszka WalczykJanusz KopczyńskiKatarzyna Lizis-KolusTomasz TrybekEstera MikinaDorota Szyska-SkrobotKlaudia Gadawska-JuszczykStefan HurejArtur SzczodryAnna SłuszniakJanusz SłuszniakRyszard MężykStanisław GóźdźAldona Kowalska

Published in: PloS one (2018)

Obesity is not associated with more aggressive clinicopathological features of thyroid cancer. Obesity is not a risk factor for progression to more advanced stages of disease, nor is it a prognostic factor for poorer treatment response and clinical outcome.

Keyphrases

prognostic factors
insulin resistance
weight gain
metabolic syndrome
weight loss
type diabetes
high fat diet induced
papillary thyroid
body mass index
squamous cell carcinoma
skeletal muscle
lymph node metastasis